DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Quinacrine is an investigational drug.
There have been 9 clinical trials for Quinacrine. The most recent clinical trial was a Phase 3 trial, which was initiated on January 1st 2005.
The most common disease conditions in clinical trials are Lupus Erythematosus, Systemic, Prion Diseases, and Lupus Erythematosus, Cutaneous. The leading clinical trial sponsors are Cleveland BioLabs, Neelesh Sharma MD PhD, and Medical Research Council.
Recent Clinical Trials for Quinacrine
|The Efficacy of OK-432 Pleurodesis on Postoperative Air Leak||National Taiwan University Hospital||N/A|
|Quinacrine-Capecitabine Combinatorial Therapy for Advanced Stage Colorectal ADenocarcinoma||Milton S. Hershey Medical Center||Phase 1/Phase 2|
|Erlotinib Hydrochloride and Quinacrine Dihydrochloride in Stage IIIB-IV Non-Small Cell Lung Cancer||Neelesh Sharma MD PhD||Phase 1|